MESYLATE TRIHYDRATE OF 5-(2-(4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL)-ETHYL)-6-CHLOR0-1,3-DIHYDRO-2H-INDOL-2-0NE
Pronalazak se odnosi na trihidratnu so mezilata 5-(-2-(4-(1,2-benzizotiazol-3-il)-1-piperazinil)-etil)-6-hloro-1,3-dihidro-2H-indol-2-ona, farmaceutske kompozicije koje sadrže navedenu trihidratnu so mezilata i metode korišćenja navedene mezilat trihidratne soli za tretman psihotičkih poremećaja. PC...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Pronalazak se odnosi na trihidratnu so mezilata 5-(-2-(4-(1,2-benzizotiazol-3-il)-1-piperazinil)-etil)-6-hloro-1,3-dihidro-2H-indol-2-ona, farmaceutske kompozicije koje sadrže navedenu trihidratnu so mezilata i metode korišćenja navedene mezilat trihidratne soli za tretman psihotičkih poremećaja.
PCT No. PCT/IB97/00306 Sec. 371 Date Mar. 2, 1999 Sec. 102(e) Date Mar. 2, 1999 PCT Filed Mar. 26, 1997 PCT Pub. No. WO97/42190 PCT Pub. Date Nov. 13, 1997Mesylate Trihydrate Salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1H)-indol-2-one (=Ziprasidone), Its Preparation and Its Use as Dopamine D2 Antagonist The invention relates to the mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1H)-indol-2-one ("ziprasidone mesylate trihydrate"), to pharmaceutical compositions containing ziprasidone mesylate trihydrate, and to methods of administering ziprasidone mesylate trihydrate to treat psychotic diseases. |
---|